Senior Management Team

Steffen Nock PhD
Acting Chief Executive Officer

Steffen Nock joined Arana in April 2005. He is the former President of Absalus Inc., having previously participated in the foundation of Zyomyx, a biotechnology company in Hayward, U.S., exploiting antibody-based proteomics technologies. Prior to this, Steffen held scientific research positions at Stanford University, U.S., and in Germany. He was one of four founders of Absalus that was acquired by Arana in April, 2005, when he became President of the company’s U.S. operation.

On 12 November 2008 Steffen was appointed Acting CEO.

Rob Crombie BA Mod Hons; PhD
Vice President, Business Development – Technology

Rob Crombie joined Arana in April 2004 and is responsible for marketing the company’s technology and products, establishing collaborative relationships and strategically in - and out-licensing technology assets. He comes from a senior business development post with ML Laboratories PLC, UK and has over 10 years of business development experience in the antibody sector. He had previously managed a technology development team in Cobra Therapeutics Ltd and was responsible, at ML Laboratories, for licensing an antibody production system to several top pharmaceutical and biotech companies.

David Fuller MBBS, B.Pharm(Hons)
Chief Medical Officer

David Fuller joined Arana in October 2007. David is dually qualified in medicine and pharmacy with more than 20 years international experience in clinical development and commercialisation of new medicines. He has previously worked at Genzyme, Orphan Medical and CeNeS in a number of senior product development roles.

Niall Henderson BAcc, CA, ACA, AICD
Chief Financial Officer and Company Secretary

Niall Henderson joined Arana in December 2001. His career encompasses periods both in the accounting profession (with Deloitte in Glasgow and Sydney) and in commerce. He has over 25 years commercial accounting experience, most of which has been spent with the international TNT transport group. He held a number of senior financial positions both in Australia and in Europe both at a corporate and divisional level. He has been significantly involved in mergers and acquisitions and most recently held the position of Director and Chief Financial Officer of TNT Australia, the major express and logistics subsidiary of the TNT Post Group.

Cliff Holloway BPharm, PhD
Vice President, Business Development - Products

Cliff Holloway joined Arana in January 2006. Following his early career in clinical research with Eli Lilly and Novartis, Cliff has since held several business development positions in drug discovery platform, software technology and biopharmaceutical companies, including for Biosym Technologies, Molecular Simulations (Accelrys), Superscape and Pharmacopeia Drug Discovery Inc. With over 20 years business experience Cliff has been instrumental in the direction and expansion of these companies’ operations in the U.S., Europe and Asia.

Phil Jennings BSc, BVSc, PhD, FTSE
Chief Scientific Officer

In addition to having over 25 years of experience in science and science management, Phil also brings a depth of practical experience in patenting, intellectual property, biological and molecular science commercialisation, and the resolution of commercial/licensing disputes. Author of a number of pioneering papers in biotechnology, Phil is also an inventor of important granted patents and patent applications (Gene Shears, Betabiotic and Arana). Prior to joining Arana, Phil was a Chief Research Scientist, Corporate Fellow and a Chief of Division at the CSIRO.